Avinger Inc (AVGR)

NASDAQ
0.5417
-0.0199(-3.54%)
After Hours
0.5302
-0.0115(-2.1229%)
- Real-time Data
  • Volume:
    12,244
  • Day's Range:
    0.5300 - 0.5800
  • 52 wk Range:
    0.4201 - 2.0500

AVGR Overview

Prev. Close
0.5616
Day's Range
0.53-0.58
Revenue
8.27M
Open
0.58
52 wk Range
0.4201-2.05
EPS
-3.07
Volume
12,244
Market Cap
5.79M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
248,829
P/E Ratio
-0.19
Beta
-
1-Year Change
-72.47%
Shares Outstanding
10,686,893
Next Earnings Date
Aug 03, 2023
What is your sentiment on Avinger?
or
Market is currently closed. Voting is open during market hours.

Avinger Inc Company Profile

Avinger Inc Company Profile

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris SV (Small Vessel).

Read More

Analyst Price Target

Average1.6000 (+195.3664% Upside)
High1.6000
Low1.6000
Price0.5417
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellSellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • yes
    0
    • Rs is coming
      0
      • the end!
        0
        • BUUUUUY
          0
          • Avinger Reports Second Quarter 2021 Financial ResultsAugust 10, 2021Pantheris Sales and Tigereye™ Expansion Drive 91% Year-Over-Year Revenue Growth
            0
            • hello any one here
              1
              • Avinger Announces 510(k) Filing for New Lightbox 3 Imaging ConsoleAugust 09, 2021Smaller Footprint, Improved User Experience and Lower Cost to Drive Adoption
                0
                • Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis IndicationJuly 06, 2021
                  0
                  • BLIN is next MRIN
                    0
                    • B. Riley Securities Initiates Coverage On Avinger with Buy Rating, Announces Price Target of $2.5
                      0